Alf Corsenca

The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis

Günther F.L. Hofbauer, A. Marcollo-Pini, Alf Corsenca et al. · British Journal of Dermatology · 2008 · 134 citations

Tuberous Sclerosis Complex, Translational Medicine, Urology +11

Posttransplant Acidosis and Associated Disorders of Mineral Metabolism in Patients With a Renal Graft

Haci Yakup Yakupoglu, Alf Corsenca, Patricia Wahl et al. · Transplantation · 2007 · 51 citations

Correction of Metabolic Acidosis with Potassium Citrate in Renal Transplant Patients and its Effect on Bone Quality

Astrid Starke, Alf Corsenca, Thomas Köhler et al. · Clinical Journal of the American Society of Nephrology · 2012 · 44 citations · Full text

Finding the Right Position: A Three-Year, Single-Center Experience with the “Self-Locating” Catheter

Brigitte Bergamin, Oliver Senn, Alf Corsenca et al. · Peritoneal Dialysis International · 2010 · 28 citations

Combined nephrectomy and pre-emptive renal transplantation in a tuberous sclerosis patient with angiomyolipoma, renal carcinoma and life-threatening abdominal haemorrhages

Alf Corsenca, Franziska Aebersold, Holger Moch et al. · Nephrology Dialysis Transplantation · 2007 · 23 citations · Full text

Pre-emptive Renal Transplantation, Immunology, Pathology +20